Association Between Vonoprazan and the Risk of Gastric Cancer After Helicobacter pylori EradicationJunya Arai, Masato Kasuga, Atsushi Miyawaki et al.|Clinical Gastroenterology and Hepatology|2024Cited by 41
Non-Helicobacter pylori Gastric Microbiome Modulates Prooncogenic Responses and Is Associated With Gastric Cancer RiskRyota Niikura, Mitsuhiro Fujishiro, Yoku Hayakawa et al.|Gastro Hep Advances|2023Cited by 35
Impaired Glycosylation of Gastric Mucins Drives Gastric Tumorigenesis and Serves as a Novel Therapeutic TargetJunya Arai, Mitsuhiro Fujishiro, Yoku Hayakawa et al.|Gastroenterology|2024Cited by 28
Letter: Potassium‐competitive acid blockers may increase the risk of gastric cancer after <i>Helicobacter pylori</i> eradication a retrospective multicentre‐cohort analysisJunya Arai, Mitsuhiro Fujishiro, Yoku Hayakawa et al.|Alimentary Pharmacology & Therapeutics|2023Cited by 7